Prime Medicine is eliminating 25% of its workforce in a restructuring that includes the company pivoting its prime ...

After decades of hype and setbacks, scientists have made impressive progress into tricking stem cells into repairing organs.

Impaired neuromusculoskeletal function due to conditions such as stroke, osteoarthritis, cerebral palsy, Parkinson's disease, ...

The Lilly announcement will extend an agreement aimed at accelerating medicine development and bolstering the ...

Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal ...

"This quarter we continued to advance our promising neurology genomic medicine pipeline and are pleased to have signed our third STAC-BBB license agreement, reinforcing that Sangamo is a ...

In addition to ALS, QurAlis is advancing a robust precision medicine pipeline to bring effective disease-modifying therapeutics to patients suffering from severe diseases defined by genetics and ...

Strategic priorities did not shift markedly, with primary attention on INO-3107's advancement and the next-generation DNA medicine platform. Management acknowledged the evolving nature of tariffs ...